-
Prof. Michal Sharon
Studying large protein complexes involved in the protein degradation pathway using a novel mass spectrometry approach.Developing novel methodological approaches for structural mass spectrometryStructure-function relationship of the signalosome complexInvestigation of the 20S ubiquitin-independent degradation pathway
Homepage
-
Prof. Abraham Shanzer
Supramolecular chemistryBiomimetic ion binders, diagnostic tools in imaging technologies (fluorescent probes) and potential therapeutic agents. Synthesis, using classical and combinatorial chemistry methods and evaluation.Synthesis and properties of molecular based devices; molecular sensors, switches and logical gates for application in nanotechnology.Surface bound functional assemblies.
Homepage
-
Prof. Zippora Shakked
Crystal structure and solution studies of DNA oligomers.Collaboration with: Donald Crothers (Yale University)DNA regulatory elementsDNA bending by adenine-thymine tractsStructural and biochemical studies of proteins involved in transcriptional regulation.The tumor-suppressor protein p53 and its interaction with DNA and the basal transcription machineryThe leukemia-related RUNX1(AML1) transcription regulator
Homepage
-
Prof. Yechiel Shai
Membrane-protein interaction and molecular recognition within the membrane milieu. Implication to the function and structure of membrane proteins.Assembly and organization of pore forming toxins and ion channels in membranes: Studies with isolated fragments and intact proteins.Molecular mechanism of membrane fusion and its inhibition: Studies with HIV and Sendai Virus.Molecular basis for cell selectivity by cytolytic antimicrobial peptides.
Homepage
-
Prof. Dan Shahar
Physics of electron's spinQuantum phase transitions: General transport studies and mesoscopics of the metal-insulator, superconductor-insulator and other transitions.Scanning tunneling experiments at ultra-low temperaturesFractional and integer quantum Hall effect and related phenomena.Experiments on materials at ultra low-temperatures.
-
Prof. Michael Sela
An aptamer strategy to target oncogenic signaling in ErbB2 carrying human tumors.Collaboration with: G. Mahlknecht , Y. Yarden G. MahlknechtSynergy of antibodies towards decreasing pancreatic cancer.Collaboration with: R. Maron, B. Schechter, Y. YardenTowards vaccination: Generation of peptide mimotopes specific for anti ErbB-2 monoclonal antibodies.Collaboration with: E. Witsch, Y. YardenMechanism of action of Copolymer 1 (Copaxone), a therapeutic vaccine against multiple sclerosis.Collaboration with: R. ArnonEffective synergism by anti ErbB-2 mAb combinations comprising one mAb against the dimerization site of ErbB-2.Collaboration with: Y. YardenMonoclonal antibodies (mAbs) to ErbB-1 and ErbB-2 receptors and their role in potential anti-tumor strategy.Collaboration with: B. Schechter, Y. YardenSynergistic effects of combinations of mAb against distinct epitopes on EGFR/ErbB-1 and ErbB-2 receptors: accelerated receptor aggregation, down regulation and inhibition of tumor growth.Collaboration with: B. Schechter, Y. Yarden
